The report titled “Wearable Injector Devices Market: Growth, Future Prospects, and Competitive Analysis, 2021 -2029” offers strategic insights into the overall wearable injector devices market along with the market size and estimates for the duration 2019 to 2029. The said research study covers in-depth analysis of wearable injector devices market segments based on injector type, usage, technology, therapeutic area end users and different geographies further segmented by countries. Wearable injector’s also known as large volume injectors are the latest trend in the injectable device market. These devices permit the injection of large volume of dosage via subcutaneous route for long duration, which offers benefits to drug developers, clinicians and patients. Most of the instances biologic therapeutics are parenteral delivery wherein high volume injection doses are often needed. Biologic therapeutics development is growing at a faster pace compared to other medication forms, this growth in the biologic market is said to in parallel drive the emergence of wearable injectors.

Wearable injectors were developed with an aim to avoid frequent hospital visits for multiple injections over a long duration in case of chronic diseases such as diabetes, cancer, cardiovascular diseases, autoimmune diseases and others. With the latest feature of smart connectivity devices, the wearable injectors can be connected via Bluetooth to the phone or via Wi-Fi connectivity to a mobile app, assuring patient adherence and can be monitored by caregivers, and medical practitioners for the concerned treatment.

It is observed that rising prevalence of chronic diseases is expected to assist the market growth of wearable injectors. According to Centers of Disease Control and Prevention (CDC) every 1 in 2 adults in the US has a chronic disease. According to The Organization for Economic Co-operation and Development (OECD), 550,000 premature deaths in working population occur due to chronic diseases annually in Europe. Amongst all the chronic diseases, cancer predominates the segment.  According to World Health Organization (WHO), cancer is the second leading cause for death, and was responsible for 8.8 million deaths in 2015. Diabetes Mellitus is one of the most prevalent chronic diseases globally and has a widespread use of subcutaneous dosage form. As per International Diabetes Federation (IDF) the global prevalence of Diabetes accounted 415 million in 2015 and is said to rise to 642 million by 2040.

For the purpose of this study, the global wearable injector device market is segmented on the basis of injector type, usage, smart connectivity options, technology, therapeutic area & end users. Injector type is further segmented into On Body & off Body. Based on Usage devices are further segmented into Disposable & Reusable devices. By technology devices are segmented into spring based, motor-driven, rotary pump, expanding battery, smart connectivity options & others. By therapeutic area devices are segmented into oncology, diabetes, cardiovascular diseases, autoimmune disorder, infectious diseases & others. Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of US$ Mn along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2016 as the base year.

The geographical segmentation of the global wearable injector devices market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. Market size and forecast for these segments during 2015 to 2025 and their CAGRs for the period 2021 to 2029 are provided in this report.

The wearable injector devices market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are SteadyMed Therapeutics, Inc., UNILIFE CORPORATION, Sensile Medical AG, Insulet Corporation, Enable Injections, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Ypsomed, Amgen, Buhler Motor GmbH, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., CeQur SA. & Others

The on-body type of injector (adhesive patch) is said to predominate the market as it ensures ease in application and does not hamper with patients daily lifestyle. This kind of injector has the benefit for dose adjustment in terms of frequency and volume, water resistance and decreased healthcare costs.  The off-body type of injector is slowly gaining demand owing to the problems with adhesive patches such as skin irritation, fitting issues and painful removal of devices.

Within this segment, semi-reusable injectors are presumed to gain larger market share compared to disposable injectors owing to advantage of not completely discarding the device thus making it more cost-efficient in comparison to the disposable injectors. The disposable type may gain profits in those therapeutic areas wherein the medication is of shorter duration.

Devices with spring based technology is presumed to account a larger market share owing to the increased demand for adhesive patches. Adhesive patches are convenient to use and ensure accurate dose administration subcutaneously. In the forecast period 2021-2029, the demand for devices with motor-driven technology is said to become predominant in the wearable injector devices market owing to its ability of accurate dose and self-administration of doses at pre-determined set timings.

In comparison with all the chronic diseases mentioned in this segment oncology predominates this segment and could grab a major share in wearable injector  devices market, owing to its rising prevalence along with increased approach for self-administration of medication in order to curb hospitalization costs. Diabetes holds second position in this segment, as wearable injectors have advantages over the insulin pumps. Other conditions would also slowly adopt the use of wearable injectors due to key factors such as patient friendly and reduces hospital costs. The demand would increase further once the reimbursement policies have been made lenient for these devices.

Wearable injectors are the latest technological advancements that enables to inject large volume doses via the subcutaneous route. Based on geographies, the wearable injector devices market are segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Among the mentioned regions, North America shows higher dominance in the wearable injector devices market. The factors that drives this market to a positive growth are a constant rising prevalence of chronic diseases, increase in advancement of technological development with smart connectivity options which helps remote monitoring by the caregivers, easy accessibility to latest technology and developed healthcare infrastructure. Asia-Pacific shows a positive growth in the forecast periods, 2021-2029 owing to catalysts such as rise in prevalence of technologically forward industrial pool in countries like Japan and China. Developing nations such as Latin America and Middle East & Africa show a sluggish growth in the forecast period which could be attributed to a slower acceptability and availability of developed technologies.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Wearable Injector Devices market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Wearable Injector Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Wearable Injector Devices market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Wearable Injector Devices market?
• Which is the largest regional market for Wearable Injector Devices market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Wearable Injector Devices market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Wearable Injector Devices market worldwide?